Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan

计划入组 312 人 · 首次发布于 2024 年 7 月 17 日

SCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates

计划入组 102 人 · 首次发布于 2026 年 3 月 16 日

Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC

计划入组 75 人 · 首次发布于 2024 年 2 月 16 日

anti-CD71 degrader-antibody conjugates (Genentech)

degrader-antibody conjugates (DELigase platform, cancer)

anti-STEAP1 degrader-antibody conjugates (prostate cancer)

Cambridge Antibody Technology

New Zealand

Latticon Antibody Therapeutics, Inc

United States

ALTEOGEN Inc.

South Korea

J&J Acquires Firefly Bio in $1 Billion Deal to Advance Pan-KRAS Degrader-Antibody Conjugates

Orum Therapeutics Appoints Chad May as Chief Scientific Officer to Advance Degrader-Antibody Conjugate Platform

Orum Therapeutics Strengthens Degrader-Antibody Conjugate Platform with Key Executive Appointment